<SEC-DOCUMENT>0001193125-16-727706-index.html : 20160930 <SEC-HEADER>0001193125-16-727706.hdr.sgml : 20160930 <ACCEPTANCE-DATETIME>20160930170114 ACCESSION NUMBER: 0001193125-16-727706 CONFORMED SUBMISSION TYPE: S-3 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20160930 DATE AS OF CHANGE: 20160930 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Galena Biopharma, Inc. CENTRAL INDEX KEY: 0001390478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-213908 FILM NUMBER: 161913464 BUSINESS ADDRESS: STREET 1: 4640 SW MACADAM AVENUE STREET 2: SUITE 270 CITY: PORTLAND STATE: OR ZIP: 97239 BUSINESS PHONE: 855 855 GALE MAIL ADDRESS: STREET 1: 4640 SW MACADAM AVENUE STREET 2: SUITE 270 CITY: PORTLAND STATE: OR ZIP: 97239 FORMER COMPANY: FORMER CONFORMED NAME: RXi Pharmaceuticals Corp DATE OF NAME CHANGE: 20110926 FORMER COMPANY: FORMER CONFORMED NAME: GALENA BIOPHARMA, INC. DATE OF NAME CHANGE: 20110922 FORMER COMPANY: FORMER CONFORMED NAME: RXI PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20110921 </SEC-HEADER> <DOCUMENT> <TYPE>S-3 <SEQUENCE>1 <FILENAME>d268898ds3.htm <DESCRIPTION>FORM S-3 <TEXT> Document 1 - file: d268898ds3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>d268898dex51.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: d268898dex51.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>3 <FILENAME>d268898dex232.htm <DESCRIPTION>EX-23.2 <TEXT> Document 3 - file: d268898dex232.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>g268898bcpg01.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: g268898bcpg01.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>g268898covpg01.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: g268898covpg01.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>g268898g10a41.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: g268898g10a41.jpg
</DOCUMENT> </SEC-DOCUMENT>